Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells. - Wikidata - awgldk - TriplyDB

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

http://www.wikidata.org/entity/Q37447008

about

Antitumor effects of flavopiridol on human uterine leiomyoma in vitro and in a xenograft model.Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.

P2860

Q34418095-14FD21D4-1F53-4B8C-A179-1D3021255E57 Q48246827-BCB0E96B-453D-44FF-9972-25F910199862

P2860

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

http://www.wikidata.org/entity/Q37447008

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 June 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@en

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@nl

type

label

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@en

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@nl

prefLabel

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@en

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@nl

P1433

Q37447008-82B2E647-F296-4219-B237-72B3D543211C

P1476

Q37447008-D8EB31F2-085A-4AB7-A61E-0CAC4A8C7D90

P2093

Q37447008-473298F0-7B64-491D-8F6E-1EE56E050204

Q37447008-6262EAF0-6590-45FA-9B4A-82973E72906C

Q37447008-7219522B-CAE6-4890-82D3-4C5CB2A11B4A

Q37447008-A4A0C0BB-D465-4819-AC83-047042230AF6

Q37447008-BED250A3-96DF-4C1B-8C0D-A0375DAEE99A

Q37447008-EFA9E763-77AD-4FFA-A341-342E5AF7852F

P2860

Q37447008-1F7213E9-4FC3-41AD-9AF6-82DAEBD1EF2E

Q37447008-234B5109-4025-4E13-8198-07FB94E5754D

Q37447008-29011475-5572-4887-86C8-EFDB3AD61E3C

Q37447008-322ED4F9-D788-4E70-B3BC-AF11DCF04439

Q37447008-37B790B5-D32D-4FE6-A28E-EDB902B4D489

Q37447008-3E5C5C66-51D3-4E29-93EA-0273C0B14DF7

Q37447008-5BE94333-01D5-428C-86B1-CEC47588323B

Q37447008-627CD0D9-A2C2-4A5A-9056-E1FAE0716204

Q37447008-69D586CD-F666-4B1A-A1AC-7F53EEB3F56E

Q37447008-6AB97C67-1202-4F75-801C-0A945C804832

P304

Q37447008-A29E3E54-3457-42B3-B390-DCC3086E6000

P31

Q37447008-8A62F33C-70D1-4947-A830-870CFB0C026A

P356

Q37447008-2DA8ECFE-5028-4841-8417-D046D58204D6

P433

Q37447008-14B580CD-5A92-47D2-AA9E-5DF2D6117B24

P478

Q37447008-136FC525-0583-403C-890D-0E08497EC807

P577

Q37447008-32EDB319-35D9-4DFA-9F8B-4A563611CF2F

P5875

Q37447008-06135565-E7F9-42DD-8CA4-A42566F34CEE

P698

Q37447008-4839DA42-1D75-446E-A218-D10D9E8B4012

P932

Q37447008-63463BBC-DF1A-433F-B87F-B2E69BF044A2

P356

CRT.2005.37.3.191

P1433

Cancer Research and Treatment

P1476

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

@en

P2093

Hong-Gyun Wu

http://www.w3.org/2001/XMLSchema#string

Hye Jin Park

http://www.w3.org/2001/XMLSchema#string

Il Han Kim

http://www.w3.org/2001/XMLSchema#string

In Ah Kim

http://www.w3.org/2001/XMLSchema#string

Jin Hee Shin

http://www.w3.org/2001/XMLSchema#string

Suzy Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275

Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis

Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells

Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy.

Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status.

Flavopiridol: pleiotropic biological effects enhance its anti-cancer activity.

Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.

The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.

P304

191-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2005.37.3.191

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40443584

http://www.w3.org/2001/XMLSchema#string

P698

19956502

http://www.w3.org/2001/XMLSchema#string

P932

2785412

http://www.w3.org/2001/XMLSchema#string